AIkido Pharma
0
0
+€0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Dividends
0%Dividend Yield
Sep 26
€0.19
May 26
€0.27
Jan 26
€0.36
Sep 25
€0.19
Mar 25
€0.31
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Financials
-20.47%Profit Margin
Unprofitable105.35MRevenue
-21.57MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.
Show more...
CEO
Anthony Hayes
Employees
4
Country
United States
ISIN
US0088751062
Listings
0 Comments
Share your thoughts
FAQ
What is AIkido Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange AIkido Pharma stocks are traded under the ticker BP2M.STU.
What is AIkido Pharma revenue for the last year?▼
AIkido Pharma revenue for the last year amounts to 105.35M EUR.
What is AIkido Pharma net income for the last year?▼
BP2M.STU net income for the last year is -21.57M EUR.
Does AIkido Pharma pay dividends?▼
Yes, BP2M.STU dividends are paid semi-annual. The last dividend per share was 0.27 EUR. As of today, Dividend Yield (FWD)% is 0%.
How many employees does AIkido Pharma have?▼
As of September 04, 2026, the company has 4 employees.
In which sector is AIkido Pharma located?▼
AIkido Pharma operates in the Technology sector.
When did AIkido Pharma complete a stock split?▼
The last stock split for AIkido Pharma was on June 07, 2022 with a ratio of 1:17.
Where is AIkido Pharma headquartered?▼
AIkido Pharma is headquartered in New York, United States.